Cardinal health 414 INC:1109813 F-18 FDG in shielded delivery and administration system
Ended Awarded Last action
- Contract number
- 75N90020F00002
- Awardee
-
Cardinal Health 414, LLC UEI CWN9UGL3NCL9 Part of Cardinal Health, Inc.
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $117,677
Award facts
- Opportunity
-
- NIHP160018F Solicitation number
- F-18 FDG Unit Doses in Shielded Delivery and Administration Containers Award Notice · Posted May 16, 2016
- Contract value 100% obligated
- $117,677.26 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Dublin, OH 43017, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$16,123 | |
| Original award | $133,800 |
About this award
Cardinal Health 414, LLC received a delivery order from the NIH Clinical Center valued at $117,677.26 for the supply of Fluorine-18 Fluorodeoxyglucose (F-18 FDG) in shielded delivery and administration systems. The contract, awarded on December 4, 2019, with an ultimate completion date of September 30, 2020, was issued on a firm fixed-price basis with no set-aside designation. Performance is based in Dublin, Ohio, where Cardinal Health 414 operates as a specialized subsidiary of Cardinal Health, Inc., focusing on the manufacturing, testing, and distribution of radiopharmaceuticals and medical isotopes to federal healthcare agencies. This delivery order supports the NIH Clinical Center's nuclear medicine and diagnostic imaging capabilities by providing time-sensitive radiopharmaceutical products essential for oncology treatment and related clinical procedures.
The award notice indicates an administrative de-obligation action in preparation for the September 30, 2026 closing of fiscal year 2021 funds in accordance with 31 U.S.C. Section 1552(a). Cardinal Health 414 has established itself as a critical single-source supplier of specialized radiopharmaceuticals to multiple federal agencies, including the Department of Veterans Affairs, Defense Health Agency, and National Institutes of Health, with an extensive portfolio of indefinite delivery contracts and blanket purchase agreements supporting routine and emergency orders of radiopharmaceutical supplies across the federal healthcare system.
Quick answers
Who was awarded contract 75N90020F00002?
75N90020F00002 was awarded to Cardinal Health 414, LLC by NIH Clinical Center (National Institutes of Health) on December 4, 2019.
How much is contract 75N90020F00002 worth?
The government has obligated $117,677 on 75N90020F00002.
Is contract 75N90020F00002 an order under another contract?
Yes. 75N90020F00002 is a delivery order under HHSN269201600005I, an indefinite delivery contract.
Was contract 75N90020F00002 competed?
The extent of competition for 75N90020F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award